Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Dexcom (DXCM)
NASDAQ:DXCM
Holding DXCM?
Track your performance easily
See the Price Targets and Ratings of:
DXCM Analyst Ratings
Strong Buy
15 Buy
4 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
DXCM Stock 12 Month Forecast
Average Price Target
$96.24
▲(37.56% Upside)
| Highest Price Target$120.00 | Average Price Target$96.24 | Lowest Price Target$75.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Wells Fargo
Assigned
10/25/24
Raymond James
Reiterated
10/25/24
Oppenheimer
Assigned
10/25/24
Jefferies
Reiterated
10/25/24
Citi
Reiterated
10/25/24
J.P. Morgan
Reiterated
10/25/24
Piper Sandler
Reiterated
10/25/24
Bank of America Securities
Reiterated
10/25/24
Stifel Nicolaus
Reiterated
10/25/24
Bernstein
Reiterated
10/25/24
Morgan Stanley
$75
Hold
7.20%
Upside
Reiterated
10/25/24
Cautious Outlook for Dexcom Amid Market Challenges and Growth Concerns
RBC Capital
$120→$115
Buy
64.38%
Upside
Reiterated
10/25/24
RBC Capital Reaffirms Their Buy Rating on Dexcom (DXCM)
BTIG
$120
Buy
71.53%
Upside
Reiterated
10/25/24
DexCom Earnings: DXCM Stock Plunges 16% Despite Beating Q3 Estimates - TipRanks.comLikewise, Marie Thibault of BTIG was encouraged by DexComs overall Q3 beat. She noted that DexCom maintained the FY24 guidance, and despite the softening U.S. sales there were numerous positives from management that project a return to higher growth in 2025.
Robert W. Baird
$82
Hold
17.21%
Upside
Reiterated
10/24/24
Dexcom's Cautious Outlook: Hold Rating Amid U.S. Revenue Decline and Growth Uncertainties
Leerink Partners
$90→$87
Buy
24.36%
Upside
Reiterated
10/24/24
Dexcom's Strategic Resilience and Growth Prospects Support Buy Rating
Best Analysts Covering Dexcom
Which Analyst Should I Follow If I Want to Buy DXCM and Sell After:
1 Month
xxx
Success Rate
26/46 ratings generated profit
Average Return
+3.24%
assigned a xxx
rating 16 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 56.52% of your transactions generating a profit, with an average return of +3.24% per trade.
3 Months
xxx
Success Rate
21/30 ratings generated profit
Average Return
+4.43%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 70.00% of your transactions generating a profit, with an average return of +4.43% per trade.
1 Year
Success Rate
32/46 ratings generated profit
Average Return
+37.30%
assigned a buy rating 16 days ago
Copying Steven Lichtman's trades and holding each position for 1 Year would result in 69.57% of your transactions generating a profit, with an average return of +37.30% per trade.
2 Years
xxx
Success Rate
34/46 ratings generated profit
Average Return
+88.28%
assigned a xxx
rating 16 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 73.91% of your transactions generating a profit, with an average return of +88.28% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
DXCM Analyst Recommendation Trends
Rating
Jun 24
Jul 24
Aug 24
Sep 24
Oct 24
Strong Buy
1
6
8
8
6
Buy
25
20
25
23
27
Hold
3
7
9
8
6
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
29
33
42
39
39
Each month's total comprises the sum of three months' worth of ratings.
DXCM Financial Forecast
DXCM Stock Forecast FAQ
What is DXCM’s average 12-month price target, according to analysts?
Based on analyst ratings, Dexcom’s 12-month average price target is $96.24.
What is DXCM’s upside potential, based on the analysts’ average price target?
Dexcom has 37.56% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is DXCM a Buy, Sell or Hold?
Dexcom has a consensus rating of Strong Buy which is based on 15 buy ratings, 4 hold ratings and 0 sell ratings.
What is Dexcom’s price target?
The average price target for Dexcom is $96.24. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $120.00 ,the lowest forecast is $75.00. The average price target represents 37.56% Increase from the current price of $69.96.
The highest analyst price target is $120.00 ,the lowest forecast is $75.00. The average price target represents 37.56% Increase from the current price of $69.96.
What do analysts say about Dexcom?
Dexcom’s analyst rating consensus is a Strong Buy. This is based on the ratings of 19 Wall Streets Analysts.
How can I buy shares of DXCM?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.